Ara
Toplam kayıt 3, listelenen: 1-3
Concurrent chemoradiotherapy with weekly carboplatin and paclitaxel may be a feasible option in inoperable stage III non-small cell lung cancer: a single center experience
(2019)
Purpose: Concurrent chemoradiotherapy (CCRT) is a standard treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC). An optimal chemotherapy regimen with concurrent thoracic radiotherapy is not ...
The Prognostic Significance of Complete Response Rates in Patients with Extensive Stage Small Cell Lung Cancer
(2019)
OBJECTIVE
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer. Platinum-etoposide chemotherapy combination is used as first line treatment. The aim of this trial is evaluate the effect of complete ...
Prognostic value of basal neutrophil lymphocyte ratio in patients with extensive stage small cell lung cancer
(2018)
Purpose: The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocytopenia are markers of poor prognosis in lung cancer patients. The aim of this trial is evaluate the prognostic significance of ...